Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events
Date first appeared online 13/11/2019
DOI 10.1001/jamacardio.2019.3080
Authors Bain S.
Journal Name JAMA Cardiology
Volume 4

Documents